EDGAR Filing Documents for 0001144204-18-052788

Form 8-K - Current report:

SEC Accession No. 0001144204-18-052788

Filing Date

2018-10-05

Accepted

2018-10-05 17:08:48

Documents

Period of Report

2018-10-02

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tv504340_8k.htm	8-K	26929
2	EXHIBIT 1.1	tv504340_ex1-1.htm	EX-1.1	256545
3	EXHIBIT 5.1	tv504340_ex5-1.htm	EX-5.1	45750
4	EXHIBIT 99.1	tv504340_ex99-1.htm	EX-99.1	15878
5	EXHIBIT 99.2	tv504340_ex99-2.htm	EX-99.2	18316
6	GRAPHIC	tv504340_ex99-1img1.jpg	GRAPHIC	9107
7	GRAPHIC	tv504340_ex99-2img1.jpg	GRAPHIC	9107
	Complete submission text file	0001144204-18-052788.txt		389940

Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000

Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800

GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-35892 | Film No.: 181111245
SIC: 2834 Pharmaceutical Preparations